Artemis Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $227M | Buy |
1,041,483
+337,485
| +48% | +$74.9M | 2.4% | 3 |
|
|
2025
Q4 | $161M | Sell |
703,998
-78,703
| -10% | -$17.9M | 1.94% | 5 |
|
|
2025
Q3 | $181M | Buy |
782,701
+104,105
| +15% | +$21.2M | 2.26% | 5 |
|
|
2025
Q2 | $126M | Buy |
678,596
+111,836
| +20% | +$20.8M | 1.61% | 11 |
|
|
2025
Q1 | $119M | Buy |
566,760
+82,933
| +17% | +$16.1M | 1.82% | 8 |
|
|
2024
Q4 | $86M | Buy |
483,827
+417,839
| +633% | +$76.8M | 1.22% | 21 |
|
|
2024
Q3 | $13M | Sell |
65,988
-267,300
| -80% | -$49.9M | 0.2% | 122 |
|
|
2024
Q2 | $57.2M | Sell |
333,288
-119,365
| -26% | -$19.8M | 0.77% | 38 |
|
|
2024
Q1 | $82.4M | Buy |
452,653
+14,963
| +3% | +$2.58M | 1.04% | 23 |
|
|
2023
Q4 | $67.8M | Buy |
437,690
+49,595
| +13% | +$7.23M | 0.98% | 27 |
|
|
2023
Q3 | $57.8M | Buy |
388,095
+86,638
| +29% | +$12.7M | 0.81% | 38 |
|
|
2023
Q2 | $40.6M | Sell |
301,457
-217,383
| -42% | -$31.9M | 0.51% | 60 |
|
|
2023
Q1 | $82.5M | Buy |
518,840
+61,560
| +13% | +$9.41M | 1.01% | 29 |
|
|
2022
Q4 | $74.3M | Buy |
457,280
+81,372
| +22% | +$12.5M | 0.84% | 44 |
|
|
2022
Q3 | $50.5M | Sell |
375,908
-124,363
| -25% | -$17.8M | 0.58% | 59 |
|
|
2022
Q2 | $77M | Buy |
500,271
+20,218
| +4% | +$3.09M | 0.79% | 42 |
|
|
2022
Q1 | $77.7M | Buy |
480,053
+80,630
| +20% | +$11.7M | 0.62% | 45 |
|
|
2021
Q4 | $54M | Buy |
399,423
+26,035
| +7% | +$3.08M | 0.39% | 83 |
|
|
2021
Q3 | $40.2M | Sell |
373,388
-58,363
| -14% | -$6.67M | 0.32% | 92 |
|
|
2021
Q2 | $48.7M | Sell |
431,751
-190,500
| -31% | -$21.5M | 0.42% | 69 |
|
|
2021
Q1 | $67.3M | Sell |
622,251
-104,740
| -14% | -$11.2M | 0.64% | 44 |
|
|
2020
Q4 | $77.9M | Buy |
726,991
+264,440
| +57% | +$25.4M | 0.81% | 32 |
|
|
2020
Q3 | $40.5M | Sell |
462,551
-150,184
| -25% | -$14.1M | 0.51% | 56 |
|
|
2020
Q2 | $60.3M | Sell |
612,735
-311,437
| -34% | -$27.4M | 0.81% | 31 |
|
|
2020
Q1 | $70.4K | Sell |
924,172
-116,413
| -11% | -$9.92M | 0.12% | 24 |
|
|
2019
Q4 | $92M | Buy |
1,040,585
+153,561
| +17% | +$12.7M | 1.16% | 18 |
|
|
2019
Q3 | $67M | Sell |
887,024
-263,288
| -23% | -$18.1M | 0.92% | 29 |
|
|
2019
Q2 | $83.4M | Buy |
1,150,312
+178,180
| +18% | +$14M | 0.99% | 27 |
|
|
2019
Q1 | $78.4M | Sell |
972,132
-885,786
| -48% | -$72.5M | 0.91% | 33 |
|
|
2018
Q4 | $171M | Buy |
1,857,918
+94,632
| +5% | +$8.32M | 2.23% | 2 |
|
|
2018
Q3 | $167M | Sell |
1,763,286
-175,461
| -9% | -$16.6M | 1.85% | 7 |
|
|
2018
Q2 | $180M | Buy |
1,938,747
+97,936
| +5% | +$9.56M | 2.45% | 5 |
|
|
2018
Q1 | $174M | Buy |
1,840,811
+189,661
| +11% | +$20.8M | 2.7% | 2 |
|
|
2017
Q4 | $160M | Buy |
1,651,150
+303,329
| +23% | +$28.6M | 2.66% | 6 |
|
|
2017
Q3 | $120M | Buy |
1,347,821
+291,987
| +28% | +$22.2M | 2.46% | 4 |
|
|
2017
Q2 | $76.5M | Buy |
1,055,834
+365,259
| +53% | +$24.6M | 1.86% | 9 |
|
|
2017
Q1 | $45M | Buy |
690,575
+196,859
| +40% | +$12.4M | 1.21% | 23 |
|
|
2016
Q4 | $30.9M | Sell |
493,716
-265,011
| -35% | -$16.2M | 0.83% | 27 |
|
|
2016
Q3 | $47.8M | Sell |
758,727
-748,689
| -50% | -$48.5M | 1.34% | 15 |
|
|
2016
Q2 | $93.3M | Sell |
1,507,416
-503,456
| -25% | -$30.7M | 2.54% | 5 |
|
|
2016
Q1 | $115M | Buy |
2,010,872
+400,085
| +25% | +$22.3M | 2.89% | 5 |
|
|
2015
Q4 | $95.4M | Sell |
1,610,787
-27,896
| -2% | -$1.61M | 2.39% | 5 |
|
|
2015
Q3 | $89.1M | Sell |
1,638,683
-354,472
| -18% | -$23.1M | 2.63% | 6 |
|
|
2015
Q2 | $134M | Buy |
1,993,155
+1,043,121
| +110% | +$68.1M | 4.34% | 4 |
|
|
2015
Q1 | $55.6M | Sell |
950,034
-650,596
| -41% | -$39.3M | 2.22% | 7 |
|
|
2014
Q4 | $105M | Buy |
1,600,630
+98,607
| +7% | +$6.22M | 4.07% | 3 |
|
|
2014
Q3 | $86.8M | Buy |
+1,502,023
| New | +$83.4M | 4.35% | 1 |
|
Other funds holding ABBV
VCM
VPM
Artemis Investment Management's ABBV Position: Q1 2026 in Review
Artemis Investment Management increased its AbbVie (ABBV) stake by 48% in Q1 2026, buying an estimated $74.9M and bringing the position to 1,041,483 shares worth $227M. The position accounts for 2.4% of the portfolio, ranked #3.
Artemis Investment Management first reported a position in ABBV in Q3 2014 and has held it in 47 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Artemis Investment Management held 1,041,483 shares of AbbVie worth $227M as of Q1 2026.
- Artemis Investment Management bought 337,485 AbbVie shares in Q1 2026, an estimated $74.9M.
- AbbVie made up 2.4% of Artemis Investment Management's portfolio in Q1 2026, its #3 holding.
- Artemis Investment Management first reported a position in AbbVie in Q3 2014 and has held it in 47 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Artemis Investment Management's 13F filing for Q1 2026, filed 13 Apr 2026.